eGnome, a microbiome specialist company, announced the patent filing for its high-precision microbiome analysis platform, 'EG Mirror,' on March 31, 2021. The platform utilizes third-generation sequencing to provide detailed analysis of gut microbiomes, reducing misclassification rates by using an expanded database. It allows species-level identification, surpassing previous genus-level analyses. This development is expected to enhance the understanding of the relationship between gut microbiomes and human health, aiding in the development of microbiome-based therapeutics.